Form 4: IGM Biosciences CFO Sells Shares to Cover Tax Obligations

IGM Biosciences, Inc.'s Chief Financial Officer, Misbah Tahir, sold 1,522 shares of common stock to satisfy tax withholding requirements related to restricted stock unit vesting.

Summary

• Misbah Tahir, the Chief Financial Officer of IGM Biosciences, Inc. (IGMS), reported a sale of common stock.
• The transaction involved the disposition of 1,522 shares of IGM Biosciences common stock.
• The shares were sold on June 16, 2025, at a weighted average sale price of $1.1992 per share.
• The sale was explicitly conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Misbah Tahir beneficially owns 178,802 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, it's explicitly for tax purposes related to RSU vesting, which is a routine and non-discretionary event, not indicative of a change in company outlook or insider confidence.

Positives

• The sale was non-discretionary, specifically for covering tax withholding obligations related to restricted stock unit vesting, rather than a discretionary sale indicating a lack of confidence.

Negatives

• The transaction resulted in a reduction of the Chief Financial Officer's direct beneficial ownership by 1,522 shares.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategy.

Management Comments

• The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common for executives receiving equity compensation. Sales to cover tax obligations upon vesting of restricted stock units are a standard practice across industries and do not typically reflect a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the reason (tax withholding) suggests no negative implications for company fundamentals or management confidence.

Key Dates

Keywords

IGM Biosciences, IGMS, Form 4, Insider Trading, Stock Sale, CFO, Misbah Tahir, Tax Withholding, Restricted Stock Units, Equity Compensation